AzTrials
AzTrials

Patient-centered CareREACH - HTNNCT07147075

Provider Skill Building for Engagement and Communication in Healthcare - Hypertension Management

A study testing REACH - Hypertension in people with Patient-centered Care, run by Duke University at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Brief Summary: The study has three main goals: The first goal is to make a skills training program that improves how doctors talk with, listen to, and work with patients. The second goal is to make sure the process of collecting data and completing the program can be done. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Patient-centered Care
What is being tested?
REACH - Hypertension
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteUnited States
Study dates
2 Sep 2025to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Doctor Cohort: Independently practicing physicians (MD, DO, PA, or NP)
  • Doctor Cohort: Responsible for a panel of primary care adult patients in the Duke Primary Care clinic
  • Patient Cohort: Receiving primary care from an enrolled DPC clinician at the enrolled DPC clinic
  • Patient Cohort: Age at least 18 years
  • Patient Cohort: Diagnosis of hypertension based on EHR ICD coding
  • Patient Cohort: Able to complete a primary care encounter without an interpreter
Show all 9Show fewer
  • Patient Cohort: Able to use the study tablet for consent, data collection, and audio-recording a clinical encounter
  • Patient Cohort, post-intervention: Not previously enrolled at any other timepoint
  • EHR Cohort: Non-urgent patient encounters for enrolled clinicians 6 months pre intervention to 6 months post intervention completion

Who cannot join

  • Doctor Cohort: Not an independently practicing physician (MD, DO, PA, or NP) at the enrolled Duke Primary Care clinic
  • Patient Cohort: Previously enrolled at any other timepoint
  • EHR Cohort: Urgent patient encounters

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Duke Primary Care South Durham

    Durham, North Carolina, 27713

Other trials in United States

About this study

Official title: Provider Skill Building for Engagement and Communication in Healthcare - Hypertension Management (REACH - Hypertension)

Brief Summary:

The study has three main goals: The first goal is to make a skills training program that improves how doctors talk with, listen to, and work with patients. The second goal is to make sure the process of collecting data and completing the program can be done. The third goal is to make sure the skills training program is feasible and acceptable for doctors.

Read more

Study Activities:

  • Doctors will first complete a questionnaire and have their patients' appointments audio-recorded.
  • Then they will go through the training program.
  • After finishing the program, doctors will have more patient appointments audio-recorded.
  • Then the doctors will complete questionnaires again and have an interview with the study team.
Being tested
REACH - Hypertension
Keywords
Clinician Training, Patient-Centered Care, Health Equity, Hypertension Management, Pilot Trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REACH - HypertensionOther

    The intervention is a skills training program for doctors that includes 3 self-paced on-line learning modules and 3 coaching sessions (one in-person and 2 virtual).

Study groups in NCT07147075
Study groupRoleWhat they receive
CliniciansExperimentalDoctors will complete the program over 5-6 weeks, requiring a total of 3 hours.
Receives: Other: REACH - Hypertension
PatientsNo interventionEnrolled patients will be asked to audio-record their clinical encounter with their enrolled primary care provider and complete two surveys. No intervention will be administered to the enrolled patients.
EHR (Electronic Health Record) CohortNo interventionEHR data will be collected on all patients of enrolled doctors. These patients will not consent, and no Intervention will be administered

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the intervention as measured by Clinician enrollment

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  2. Feasibility of the intervention as measured by Patient enrollment

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  3. Feasibility of the intervention as measured by number of participants with completion of analyzable audio-recorded encounters

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  4. Feasibility of the intervention as measured by the number of participants with intervention completion

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  5. Feasibility of the intervention as measured by the number of participants with survey completion

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  6. Feasibility of the intervention as measured by the number of participants with usable electronic health record (EHR) data

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  7. Change in patient-centeredness as measured by Roter interaction analysis system (RIAS)

    Primary outcome for audio-recorded clinical encounters, the primary outcome is change in patient-centeredness, which includes behaviors like exploring the patient's perspective, showing empathy, and involving the patient in decision-making. This measure will be assessed using the Roter interaction analysis system (RIAS), a method for coding medical dialogue. The system codes each utterance (the smallest meaningful unit of speech) into one of approximately 40 categories related to task-focused or socioemotional communication. The scores derived are typically percentages or frequencies of specific communication behaviors within a given interaction (e.g., percentage of doctor talk, patient questions, or empathetic statements). A higher score is generally associated with more patient-centered communication.

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  8. Change in systolic blood pressure

    A lower (mean) systolic blood pressure may suggest the intervention was effective.

    Measured: Baseline - [spanning 6 months pre-intervention for all patients of the enrolled clinicians] to end point - [spanning 6 months post-intervention for all patients of the enrolled clinicians]

Secondary outcomes (8)
  1. Change in diastolic blood pressure

    A lower (mean) diastolic blood pressure may suggest the intervention was effective.

    Measured: Baseline - [spanning 6 months pre-intervention for all patients of the enrolled clinicians] to end point - [spanning 6 months post-intervention for all patients of the enrolled clinicians]

  2. Change in hypertension control as defined by Healthcare Effectiveness Data and Information Set (HEDIS) criteria

    Secondary Outcomes for EHR data is hypertension control defined by Healthcare Effectiveness Data and Information Set (HEDIS) criteria. HEDIS criteria are grouped into six domains: Effectiveness of Care, Access/Availability of Care, Experience of Care, Utilization and Risk Adjusted Utilization, Health Plan Descriptive Information, and Measures Reported Using Electronic Clinical Data Systems. HEDIS measures are used to evaluate performance on important dimensions of care and service, and are crucial for quality improvement and value-based care initiatives. A high score may suggest the intervention was effective.

    Measured: Baseline - [spanning 6 months pre-intervention for all patients of the enrolled clinicians] to end point - [spanning 6 months post-intervention for all patients of the enrolled clinicians].

  3. Change in treatment intensification

    Secondary Outcome for EHR data is treatment intensification (a measure of therapeutic inertia). These scores are calculated by comparing observed medication changes with expected changes, often based on clinical guidelines or individual patient needs. These scores range from -1 to +1. A score of 0 indicates perfect responsiveness to treatment goals, while -1 represents complete neglect, and +1 suggests excessive aggression in treatment adjustments.

    Measured: Baseline - [spanning 6 months pre-intervention for all patients of the enrolled clinicians] to end point - [spanning 6 months post-intervention for all patients of the enrolled clinicians]

  4. Change in verbal dominance as measured by Roter interaction analysis system (RIAS)

    Secondary outcome for audio-recorded encounters is verbal dominance. This measure will be assessed using the Roter interaction analysis system (RIAS), a method for coding medical dialogue. The scores derived are typically percentages or frequencies of specific communication behaviors within a given interaction. The RIAS defines verbal dominance as a reflection of the patient's overall participation in the consultation, measured by their total speech time in relation to the physician's speech time. Greater change scores may suggest the intervention was effective.

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  5. Change in story questions as measured by Roter interaction analysis system (RIAS)

    Secondary outcome for audio-recorded encounters is story questions (lifestyle and psychosocial topics queried by the clinician). This measure will be assessed using the Roter interaction analysis system (RIAS), a method for coding medical dialogue. The scores derived are typically percentages or frequencies of specific communication behaviors within a given interaction. Greater change scores may suggest the intervention was effective.

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  6. Change in partnering behaviors as measured by Roter interaction analysis system (RIAS)

    Secondary outcome for audio-recorded encounters is partnering behaviors such as fostering active participation and collaboration with patients. This measure will be assessed using the Roter interaction analysis system (RIAS), a method for coding medical dialogue. The scores derived are typically percentages or frequencies of specific communication behaviors within a given interaction. Greater change scores may suggest the intervention was effective.

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  7. Change in emotional statements as measured by Roter interaction analysis system (RIAS)

    Secondary outcome for audio-recorded encounters is emotional statements. These measure will be assessed using the Roter interaction analysis system (RIAS), a method for coding medical dialogue. The scores derived are typically percentages or frequencies of specific communication behaviors within a given interaction. Greater change scores may suggest the intervention was effective.

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

  8. Change in encounter duration as measured by Roter interaction analysis system (RIAS)

    Secondary outcome for audio-recorded encounters is encounter duration. This measure will be assessed by the length of the recorded dialogue of the Roter interaction analysis system (RIAS), a method for coding medical dialogue. Longer recorded encounters may suggest the interventon was effective.

    Measured: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2025
  2. Study start2 Sep 2025
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07147075
Sponsor's protocol ID
Pro00115680
Other IDs
R34HL174728
Acronym
REACH - HTN
Status last verified
Aug 2026
First submitted
21 Aug 2025
Last updated
8 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual Particpant Data (IPD) will not be shared

Questions about this trial

What is this clinical trial studying?

A study testing REACH - Hypertension in people with Patient-centered Care, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the intervention as measured by Clinician enrollment (time frame: Baseline (pre-intervention), within 6 weeks post-intervention, and 12-16 weeks post-intervention). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in